These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34818323)

  • 1. Expression of Spred2 in the urothelial tumorigenesis of the urinary bladder.
    Oda S; Fujisawa M; Chunning L; Ito T; Yamaguchi T; Yoshimura T; Matsukawa A
    PLoS One; 2021; 16(11):e0254289. PubMed ID: 34818323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bladder Tumor Subtype Commitment Occurs in Carcinoma
    Wullweber A; Strick R; Lange F; Sikic D; Taubert H; Wach S; Wullich B; Bertz S; Weyerer V; Stoehr R; Breyer J; Burger M; Hartmann A; Strissel PL; Eckstein M
    Cancer Res; 2021 Mar; 81(6):1552-1566. PubMed ID: 33472889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder.
    Masuda N; Murakami K; Kita Y; Hamada A; Kamada M; Teramoto Y; Sakatani T; Matsumoto K; Sano T; Saito R; Okuno Y; Ogawa O; Kobayashi T
    Am J Pathol; 2020 Aug; 190(8):1752-1762. PubMed ID: 32339497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of arsenic and N-butyl-N-(4-hydroxybutyl)nitrosamine on urothelial carcinogenesis in mice.
    Dai YC; Wang SC; Haque MM; Lin WH; Lin LC; Chen CH; Liu YW
    PLoS One; 2017; 12(10):e0186214. PubMed ID: 29016672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inducing cell proliferation inhibition and apoptosis via silencing Dicer, Drosha, and Exportin 5 in urothelial carcinoma of the bladder.
    Han Y; Liu Y; Gui Y; Cai Z
    J Surg Oncol; 2013 Feb; 107(2):201-5. PubMed ID: 22766726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma.
    Conconi D; Panzeri E; Redaelli S; Bovo G; Volante M; Viganò P; Strada G; Dalprà L; Bentivegna A
    BMC Res Notes; 2012 Oct; 5():607. PubMed ID: 23114535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New insights into the influence of cigarette smoking on urothelial carcinogenesis: smoking-induced gene expression in tumor-free urothelium might discriminate muscle-invasive from nonmuscle-invasive urothelial bladder cancer.
    Gabriel U; Li L; Bolenz C; Steidler A; Kränzlin B; Saile M; Gretz N; Trojan L; Michel MS
    Mol Carcinog; 2012 Nov; 51(11):907-15. PubMed ID: 21976419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and molecular markers of urothelial premalignancy and malignancy.
    Cordon-Cardo C; Cote RJ; Sauter G
    Scand J Urol Nephrol Suppl; 2000; (205):82-93. PubMed ID: 11144907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CIS is a surrogate marker of genetic instability and field carcinogenesis in the urothelial mucosa.
    Palmeira C; Lameiras C; Amaro T; Lima L; Koch A; Lopes C; Oliveira PA; Santos L
    Urol Oncol; 2011; 29(2):205-11. PubMed ID: 19854077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. H-RAS mutation is a key molecular feature of pediatric urothelial bladder cancer. A detailed report of three cases.
    Castillo-Martin M; Collazo Lorduy A; Gladoun N; Hyun G; Cordon-Cardo C
    J Pediatr Urol; 2016 Apr; 12(2):91.e1-7. PubMed ID: 26522772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX4 expression levels in urothelial bladder carcinoma.
    Gunes S; Yegin Z; Sullu Y; Buyukalpelli R; Bagci H
    Pathol Res Pract; 2011 Jul; 207(7):423-7. PubMed ID: 21680105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased DNA methyltransferase 1 protein expression in human transitional cell carcinoma of the bladder.
    Nakagawa T; Kanai Y; Saito Y; Kitamura T; Kakizoe T; Hirohashi S
    J Urol; 2003 Dec; 170(6 Pt 1):2463-6. PubMed ID: 14634451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A genetically defined disease model reveals that urothelial cells can initiate divergent bladder cancer phenotypes.
    Wang L; Smith BA; Balanis NG; Tsai BL; Nguyen K; Cheng MW; Obusan MB; Esedebe FN; Patel SJ; Zhang H; Clark PM; Sisk AE; Said JW; Huang J; Graeber TG; Witte ON; Chin AI; Park JW
    Proc Natl Acad Sci U S A; 2020 Jan; 117(1):563-572. PubMed ID: 31871155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ETV5 links the FGFR3 and Hippo signalling pathways in bladder cancer.
    di Martino E; Alder O; Hurst CD; Knowles MA
    Sci Rep; 2019 Apr; 9(1):5740. PubMed ID: 30952872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential expression of EphB2 and EphB4 receptor kinases in normal bladder and in transitional cell carcinoma of the bladder.
    Li X; Choi WW; Yan R; Yu H; Krasnoperov V; Kumar SR; Schuckman A; Klumpp DJ; Pan CX; Quinn D; Gill IS; Gill PS; Liu R
    PLoS One; 2014; 9(8):e105326. PubMed ID: 25148033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
    Hsieh HY; Jou YC; Tung CL; Tsai YS; Wang YH; Chi CL; Lin RI; Hung SK; Chuang YM; Wu SF; Li C; Shen CH; Chan MWY; Hsu CD
    Oncogene; 2018 Feb; 37(5):673-686. PubMed ID: 29035390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
    Yee CH; Zheng Z; Shuman L; Yamashita H; Warrick JI; Wu XR; Raman JD; DeGraff DJ
    Sci Rep; 2019 Jan; 9(1):270. PubMed ID: 30670749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial tumorigenesis: a tale of divergent pathways.
    Wu XR
    Nat Rev Cancer; 2005 Sep; 5(9):713-25. PubMed ID: 16110317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 protein and Ki-67 overexpression in urothelial dysplasia of bladder.
    Sun W; Zhang PL; Herrera GA
    Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):327-31. PubMed ID: 12607601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spred2 Regulates High Fat Diet-Induced Adipose Tissue Inflammation, and Metabolic Abnormalities in Mice.
    Ohkura T; Yoshimura T; Fujisawa M; Ohara T; Marutani R; Usami K; Matsukawa A
    Front Immunol; 2019; 10():17. PubMed ID: 30723473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.